- Home
- PBYI vs SUPX Comparison
PBYI vs SUPX Comparison
Compare PBYI & SUPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SUPX
- Stock Information
- Founded
- PBYI 2010
- SUPX 2021
- Country
- PBYI United States
- SUPX Singapore
- Employees
- PBYI N/A
- SUPX N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SUPX
- Sector
- PBYI Health Care
- SUPX
- Exchange
- PBYI Nasdaq
- SUPX Nasdaq
- Market Cap
- PBYI 167.3M
- SUPX 199.4M
- IPO Year
- PBYI N/A
- SUPX 2024
- Fundamental
- Price
- PBYI $3.24
- SUPX $9.68
- Analyst Decision
- PBYI Strong Buy
- SUPX
- Analyst Count
- PBYI 1
- SUPX 0
- Target Price
- PBYI $7.00
- SUPX N/A
- AVG Volume (30 Days)
- PBYI 347.1K
- SUPX 113.3K
- Earning Date
- PBYI 07-31-2025
- SUPX 08-15-2025
- Dividend Yield
- PBYI N/A
- SUPX N/A
- EPS Growth
- PBYI 143.51
- SUPX N/A
- EPS
- PBYI 0.77
- SUPX N/A
- Revenue
- PBYI $232,709,000.00
- SUPX $1,978,875.00
- Revenue This Year
- PBYI N/A
- SUPX N/A
- Revenue Next Year
- PBYI N/A
- SUPX N/A
- P/E Ratio
- PBYI $4.40
- SUPX N/A
- Revenue Growth
- PBYI 2.68
- SUPX N/A
- 52 Week Low
- PBYI $2.23
- SUPX $2.75
- 52 Week High
- PBYI $4.13
- SUPX $14.42
- Technical
- Relative Strength Index (RSI)
- PBYI 50.17
- SUPX N/A
- Support Level
- PBYI $3.38
- SUPX N/A
- Resistance Level
- PBYI $3.70
- SUPX N/A
- Average True Range (ATR)
- PBYI 0.18
- SUPX 0.00
- MACD
- PBYI -0.03
- SUPX 0.00
- Stochastic Oscillator
- PBYI 35.82
- SUPX 0.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.